高危非致残性缺血性脑血管事件定义及预测模型

doi:10.3969/j.issn.1673-5765.2018.05.013

摘要/Abstract

摘要：

高危非致残性缺血性脑血管事件（high r isk n on-disabling ischemic cerebrovascular events， HR-NICE）患者处于不稳定状态，早期复发进展为严重卒中的风险较高。目前，不同的临床评分系统是临床工作者常用的预测模型，但随着近些年对影像及分子标记物研究的深入，发现其同样能够预测卒中复发风险，进而指导HR-NICE人群的早期干预及个体化治疗，从而改善患者预后、降低致残率，同时可以降低国家卒中负担。本文根据近年对于卒中复发风险预测模型的相关研究，对HR-NICE的定义、临床、影像和分子标记物研究进展进行综述，为临床工作者提供其预后评判参考。

文章导读： 本文对高危非致残性脑血管事件患者卒中复发及预后预测模型进行了综述，对有价值的影像和分子预测标志物研究现状和前景进行了分析。

关键词: 高危非致残性缺血性脑血管事件; 短暂性脑缺血发作; 轻型卒中; 预测模型

Abstract:

The patients who have high risk non-disabling ischemic cerebrovascular events are in unstable state, and they have high risks of early recurrent stroke. At present, different clinical scoring systems are widely used, with the development of the imaging and molecular biology, these technology can be used to predict recurrent stroke risk, so that early intervention and individual therapy can be provided for patients. It could improve prognosis and reduce the disability rate and burden of stroke. This paper aims to discuss the definition of HR-NICE and predictors of clinical, imaging and molecule for recurrent stroke prediction models according to recent studies, so as to provide reference for clinical work.

Key words: High risk non-disabling ischemic cerebrovascular events; Transient ischemic attack; Minor stroke; Prediction model

韩冲, 陈玮琪, 荆京, 王伊龙, 王拥军. 高危非致残性缺血性脑血管事件定义及预测模型[J]. 中国卒中杂志, 2018, 13(05): 477-482.

HAN Chong, CHEN Wei-Qi, JING Jing, WANG Yi-Long, WANG Yong-Jun. Definition and Prediction Models for High-Risk Non-Disabling Ischemic Cerebrovascular Events[J]. Chinese Journal of Stroke, 2018, 13(05): 477-482.

参考文献

[1] 中国卒中学会. 高危非致残性缺血性脑血管事件诊

疗指南[J]. 中国卒中杂志，2016，6（6）：481-491

[2] JOHNSTON S C，GRESS D R，BROWNER W S，et

al. Short-term prognosis after emergency department

diagnosis of TIA[J]. Jama，2000，284（22）：2901-

2906.

[3] ROTHWELL P M，GILES M F，FLPSSMANN E，

et al. A simple score（ABCD）to identify individuals

at high early risk of stroke after transient ischaemic

attack[J]. Lancet，2005，366（9479）：29-36.

[4] JOHNSTON S C，ROTHWELL P M，NGUYENHUYNH

M N，et al. Validation and refinement of

scores to predict very early stroke risk after transient

ischaemic attack[J]. Lancet，2007，369（9558）：283-

292.

[5] KERNAN W N，HORWITZ R I，BRASS L M，et al.

A prognostic system for transient ischemia or minor

stroke[J]. Ann Intern Med，1991，114（7）：552-557.

[6] CAPRIE steering committee. A randomised，blinded，

trial of clopidogrel versus aspirin in patients at risk

of ischaemic events（CAPRIE）[J]. Lancet，1996，

348（9038）：1329-1339.

[7] KERNAN W N，VISCOLI C M，BRASS L M，et

al. The stroke prognosis instrument II（SPI-II）：A

clinical prediction instrument for patients with

transient ischemia and nondisabling ischemic

stroke[J]. Stroke，2000，31（2）：456-462.

[8] MERWICK A，ALBERS G W，AMARENCO

P，et al. Addition of brain and carotid imaging

to the ABCD2 score to identify patients at early

risk of stroke after transient ischaemic attack：A

multicentre observational study[J]. Lancet Neurol，

2010，9（11）：1060-1069.

[9] DIENER H C，RINGLEB P A，SAVI P. Clopidogrel

for the secondary prevention of stroke[J]. Expert

Opin Pharmacother，2005，6（5）：755-764. [10] COUTTS S B，ELIASZIW M，HILL M D，et al. An

improved scoring system for identifying patients at

high early risk of stroke and functional impairment

after an acute transient ischemic attack or minor

stroke[J]. Int J Stroke，2008，3（1）：3-10.

[11] GILES M F，ALBERS G W，AMARENCO P，et

al. Addition of brain infarction to the ABCD2 Score

（ABCD2I）：A collaborative analysis of unpublished

data on 4574 patients[J]. Stroke，2010，41（9）：1907-

1913.

[12] SONG R R，YU X F，YERFAN J，et al. Cerebral

lesions of DWI hyperintensity in patients with

subacute stroke assessed by intravoxel incoherent

motion technique[J]. Zhejiang Da Xue Xue Bao Yi

Xue Ban，2015，44（6）：632-637，644.

[13] SONG B，FANG H，ZHAO L，et al. Validation

of the ABCD3-I score to predict stroke risk after

transient ischemic attack[J]. Stroke，2013，44（5）：

1244-1248.

[14] SATO S，UEHARA T，OHARA T，et al. Factors

associated with unfavorable outcome in minor

ischemic stroke[J]. Neurology，2014，83（2）：174-

181.

[15] FERRARI J，KNOFLACH M，KIECHL S，et al.

Early clinical worsening in patients with TIA or

minor stroke：the Austrian Stroke Unit Registry[J].

Neurology，2010，74（2）：136-141.

[16] CAMDEN M C，HILL M D，DEMCHUK A M，et

al. Historic Stroke Motor Severity Score Predicts

Progression in TIA/Minor Stroke[J]. Can J Neurol

Sci，2014，41（1）：19-23.

[17] WU L，WANG A，WANG X，et al. Factors for

short-term outcomes in patients with a minor stroke：

results from China National Stroke Registry[J/OL].

BMC Neurol，2015，15：253. https：//doi.org/10.1186/

s12883-015-0505-z.

[18] ZHANG C，ZHAO X，WANG C，et al. Prediction

factors of recurrent ischemic events in one year

after minor stroke[J/OL]. PloS One，2015，10

（3）：e0120105. https：//doi.org/10.1371/journal.

pone.0120105.

[19] HORTON M，MODI J，PATEL SK，et al.

Refinement of imaging predictors of recurrent

events following transient ischemic attack and minor

stroke[J/OL]. PloS One，2013，8（6）：e65752. https：

//doi.org/10.1371/journal.pone.0065752.

[20] LIU L，WONG KS，LENG X，et al. Dual antiplatelet

therapy in stroke and ICAS：Subgroup analysis of

CHANCE[J]. Neurology，2015，85（13）：1154-1162.

[21] GONG X，ZOU X，LIU L，et al. Prognostic value

of inflammatory mediators in 1-year outcome of

acute ischemic stroke with middle cerebral artery

stenosis[J/OL]. Mediators Inflamm，2013，2013：

850714. https：//doi.org/10.1155/2013/850714.

[22] LI J，WANG Y，LIN J，et al. Soluble CD40L Is a

Useful Marker to Predict Future Strokes in Patients

With Minor Stroke and Transient Ischemic Attack[J].

Stroke，2015，46（7）：1990-1992.

[23] LIN J，ZHENG H，CUCCHIARA B L，et al.

Association of Lp-PLA2-A and early recurrence

of vascular events after tia and minor stroke[J].

Neurology，2015，85（18）：1585-1591.

[24] MULLEN M T，MESSE S R，KASNER S E，et al.

Anti-Phosphatidylserine-Prothrombin Antibodies

are Associated with Outcome in a TIA Cohort[J/OL].

Front Neurol，2012，3：137. https：//doi.org/10.3389/

fneur.2012.00137.

[25] GREISENEGGER S，SEGAL H C，BURGESS A

I，et al. Biomarkers and mortality after transient

ischemic attack and minor ischemic stroke：

Population-based study[J]. Stroke，2015，46（3）：

659-666.

[26] LI J，WANG Y，WANG D，et al. Glycated albumin

predicts the effect of dual and single antiplatelet

therapy on recurrent stroke[J]. Neurology，2015，84

（13）：1330-1336.